Re: [Gnumed-devel] Re: Drug interactions software -- significance and design considerations

[Karsten Hilbert]

On Tue, Aug 03, 2010 at 12:09:15PM -0700, Jim Busser wrote:

>> Larger vendors will often point to the yearly fees they have to pay to their 
>> middleware vendors as the justification for the higher maintenance fees and 
>> to some degree this is true.

Same here and I do think it makes sense.

> This, with FreeDiams, is not the case, however I can
> understand how companies which bring in revenues might spend
> extra time to improve their data sources.

The data sources can indeed be improved. Checking drug
status (on market etc), checking literature for
interactions, ...

> What should be the thinking about allowing users to
> contribute interactions to FreeDiams, and of providing the
> references?

I tend to think that 99% of all users will not participate.
The rest are 50% crazy and 50% really sane. The trick is the
identify the latter. IMO there's no difference to meatspace
- building relationships.

Karsten
-- 
GPG key ID E4071346 @ wwwkeys.pgp.net
E167 67FD A291 2BEA 73BD  4537 78B9 A9F9 E407 1346